Trials / Active Not Recruiting
Active Not RecruitingNCT05817942
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
A Prospective, Non-interventional, Multi-country Cohort Study of the Effectiveness and Safety of Filgotinib in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 509 (actual)
- Sponsor
- Alfasigma S.p.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To describe the effectiveness, treatment patterns, quality of life, and safety of participants with moderately or severely active UC treated with filgotinib in a real-world setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Filgotinib | Jyseleca |
Timeline
- Start date
- 2023-06-12
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2023-04-18
- Last updated
- 2025-12-24
Locations
81 sites across 10 countries: Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT05817942. Inclusion in this directory is not an endorsement.